We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
55 hedge funds and large institutions have $97.4M invested in Corcept Therapeutics in 2014 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 20 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $102M → $97.4M (-$4.44M)
11% less funds holding
Funds holding: 62 → 55 (-7)
35% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 20
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Holders
55
Holders Change
-7
Holders Change %
-11.29%
% of All Funds
1.6%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
13
Reduced
20
Closed
10
Calls
$109K
Puts
–
Net Calls
+$109K
Net Calls Change
+$43K
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$457K |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$271K |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
-$213K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$147K |
| 5 |
TG
TCW Group
Los Angeles,
California
|
-$103K |
